NCT07729397 Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30) Status NOT_YET_RECRUITING Phase PHASE1
NCT07710781 Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies Status NOT_YET_RECRUITING Phase NA
NCT07641010 PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07576725 Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial Status NOT_YET_RECRUITING Phase PHASE2
NCT07566377 Cord Blood Transplantation in Children and Young Adults With Blood Cancer Status RECRUITING Phase PHASE2
NCT07551583 Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL Status RECRUITING Phase PHASE2
NCT07514819 Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma Status RECRUITING Phase NA
NCT07444632 Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies Status RECRUITING Phase PHASE1
NCT07374068 Prognostic Model of Elderly Hodgkin Lymphoma in China Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07285044 The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas Status RECRUITING Phase PHASE2
NCT07270679 Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation. Status RECRUITING Phase N/A
NCT07259304 Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07256158 PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma Status NOT_YET_RECRUITING Phase PHASE3
NCT07234487 Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL Status RECRUITING Phase PHASE2
NCT07222345 Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma Status RECRUITING Phase NA
NCT07209059 PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma Status RECRUITING Phase PHASE2
NCT07188090 Mozobil for Autologous Hematopoietic Stem Cell Transplantation Status RECRUITING Phase PHASE2
NCT07164469 Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma Status NOT_YET_RECRUITING Phase PHASE2